HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dong Xu Selected Research

Hyperoxia

7/2009Knockdown of ERp57 increases BiP/GRP78 induction and protects against hyperoxia and tunicamycin-induced apoptosis.
3/2009Heat shock protein 27 protects lung epithelial cells from hyperoxia-induced apoptotic cell death.
1/2008Epidermal growth factor-like domain 7 protects endothelial cells from hyperoxia-induced cell death.
11/2006Mitochondrial aldehyde dehydrogenase attenuates hyperoxia-induced cell death through activation of ERK/MAPK and PI3K-Akt pathways in lung epithelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dong Xu Research Topics

Disease

108Neoplasms (Cancer)
05/2024 - 08/2002
26Infections
11/2023 - 11/2003
22Breast Neoplasms (Breast Cancer)
05/2024 - 08/2004
19Systemic Lupus Erythematosus (Libman-Sacks Disease)
12/2023 - 08/2002
19Colorectal Neoplasms (Colorectal Cancer)
11/2023 - 01/2004
16Inflammation (Inflammations)
01/2024 - 03/2012
15Chronic Hepatitis B
01/2022 - 11/2003
14COVID-19
09/2022 - 01/2020
14Hepatocellular Carcinoma (Hepatoma)
01/2022 - 02/2008
11Fibrosis (Cirrhosis)
01/2024 - 10/2006
11Thyroid Neoplasms (Thyroid Cancer)
10/2023 - 01/2010
10Arthritis (Polyarthritis)
01/2024 - 04/2003
10Neoplasm Metastasis (Metastasis)
12/2023 - 12/2017
10Systemic Scleroderma (Systemic Sclerosis)
12/2023 - 01/2013
9Lung Neoplasms (Lung Cancer)
04/2024 - 11/2010
9Autoimmune Diseases (Autoimmune Disease)
01/2024 - 01/2014
9Pancreatic Neoplasms (Pancreatic Cancer)
02/2023 - 01/2010
8Carcinogenesis
04/2024 - 08/2013
8Dermatomyositis (Dermatopolymyositis)
01/2024 - 01/2016
8Myocardial Infarction
03/2023 - 09/2011
7Myositis (Idiopathic Inflammatory Myopathies)
07/2023 - 11/2016
7Epilepsy (Aura)
10/2022 - 07/2015
7Necrosis
06/2021 - 02/2013
6Coronary Artery Disease (Coronary Atherosclerosis)
01/2024 - 07/2014
6Hypoxia (Hypoxemia)
12/2023 - 07/2008
6Adenocarcinoma
08/2023 - 12/2020
6Cardiovascular Diseases (Cardiovascular Disease)
12/2022 - 08/2014
6Connective Tissue Diseases (Connective Tissue Disease)
01/2021 - 08/2013
6Glioma (Gliomas)
05/2017 - 11/2009
5Interstitial Lung Diseases (Interstitial Lung Disease)
01/2024 - 08/2013
5Rheumatoid Arthritis
10/2023 - 09/2010
5Stomach Neoplasms (Stomach Cancer)
08/2021 - 01/2012
5Thrombocytopenia (Thrombopenia)
01/2021 - 09/2011
5Acute Coronary Syndrome
11/2018 - 01/2016
5Pain (Aches)
11/2015 - 12/2010
4Follicular Adenocarcinoma
05/2024 - 09/2020
4Thyroid Nodule (Nodule, Thyroid)
03/2024 - 01/2023
4Lung Injury
12/2023 - 07/2009
4Colonic Neoplasms (Colon Cancer)
11/2023 - 10/2011
4Depressive Disorder (Melancholia)
10/2023 - 01/2021
4Stroke (Strokes)
03/2023 - 01/2018
4Hypertension (High Blood Pressure)
02/2023 - 01/2014
4Alzheimer Disease (Alzheimer's Disease)
01/2023 - 01/2022
4Osteosarcoma (Osteogenic Sarcoma)
01/2023 - 12/2016
4Seizures (Absence Seizure)
10/2022 - 10/2016
4Carcinoma (Carcinomatosis)
12/2021 - 07/2014

Drug/Important Bio-Agent (IBA)

54Proteins (Proteins, Gene)FDA Link
12/2023 - 04/2003
27Biomarkers (Surrogate Marker)IBA
05/2024 - 01/2012
17Messenger RNA (mRNA)IBA
12/2023 - 12/2003
13RNA (Ribonucleic Acid)IBA
04/2024 - 07/2015
13AntibodiesIBA
02/2024 - 03/2012
13CytokinesIBA
01/2024 - 11/2014
13DNA (Deoxyribonucleic Acid)IBA
01/2020 - 04/2004
12Long Noncoding RNAIBA
05/2022 - 11/2016
11C-Reactive ProteinIBA
02/2024 - 06/2014
11MicroRNAs (MicroRNA)IBA
11/2021 - 01/2013
9AutoantibodiesIBA
01/2024 - 08/2002
8Antiviral Agents (Antivirals)IBA
01/2024 - 01/2007
8entecavirFDA Link
01/2022 - 01/2007
8EnzymesIBA
01/2022 - 04/2003
8Lamivudine (Epivir)FDA Link
12/2008 - 11/2003
7Therapeutic UsesIBA
11/2023 - 10/2013
6RacivirIBA
05/2024 - 01/2019
6GlucocorticoidsIBA
12/2023 - 09/2011
6AlbuminsIBA
02/2023 - 01/2019
6ImmunosorbentsIBA
01/2022 - 04/2003
6honokiolIBA
06/2021 - 11/2006
6Immunoglobulin G (IgG)IBA
01/2015 - 08/2002
6NucleosidesIBA
03/2011 - 01/2007
5AlginatesIBA
11/2023 - 01/2019
5CateninsIBA
10/2023 - 01/2014
5Capecitabine (Xeloda)FDA Link
08/2023 - 12/2020
5Oxaliplatin (Eloxatin)FDA LinkGeneric
08/2023 - 12/2020
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2023 - 01/2010
5Immunosuppressive Agents (Immunosuppressants)IBA
09/2022 - 05/2007
5Phosphotransferases (Kinase)IBA
07/2021 - 09/2009
5Hepatitis B e AntigensIBA
04/2019 - 04/2004
5omega-Chloroacetophenone (Mace)IBA
11/2018 - 01/2016
5Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2013 - 09/2002
4LigandsIBA
04/2024 - 04/2009
4Immune Checkpoint InhibitorsIBA
01/2024 - 08/2021
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2024 - 01/2013
4B-Cell Activating FactorIBA
12/2023 - 08/2002
4hydrogen sulfite (bisulfite)IBA
10/2023 - 09/2010
4Alanine Transaminase (SGPT)IBA
08/2023 - 04/2010
4GemcitabineFDA Link
01/2023 - 01/2010
4GABA Plasma Membrane Transport ProteinsIBA
10/2022 - 10/2019
4fibrin fragment D (D-dimer)IBA
10/2021 - 01/2020
4Interleukin-6 (Interleukin 6)IBA
01/2021 - 03/2015
4Interleukin-10 (Interleukin 10)IBA
01/2021 - 06/2018

Therapy/Procedure

70Therapeutics
05/2024 - 09/2002
16Drug Therapy (Chemotherapy)
05/2024 - 07/2010
10Immunotherapy
04/2024 - 01/2020
6Neoadjuvant Therapy
11/2023 - 07/2018
6Length of Stay
01/2023 - 01/2016
6Radiofrequency Ablation
01/2023 - 11/2014
5Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2024 - 10/2021
5Thyroidectomy
10/2023 - 07/2011
5Aftercare (After-Treatment)
08/2023 - 07/2014
4Adjuvant Chemotherapy
01/2022 - 05/2016